Clinical Trial Update: A Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen [Phase 1, Phase 2]

View source ↗

Summary

A study evaluating a novel furosemide regimen for acute decompensated heart failure has been withdrawn from Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: Todd M Koelling, MD | Conditions: Acute Decompensated Heart Failure | Phase 1, Phase 2 | Status: WITHDRAWN